Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment
Open accessAbstract
In prostate cancer, cancer-associated fibroblasts (CAF) exhibit contrasting biological properties to non-malignant prostate fibroblasts (NPF) and promote tumorigenesis.Resolving intercellular signaling pathways between CAF and prostate tumor epithelium may offer novel opportunities for research translation.To this end, the proteome and phosphoproteome of four pairs of patient-matched CAF and NPF were characterized to identify discriminating proteomic signatures.Samples were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/ MS) with a hyper reaction monitoring data-independent acquisition (HRM-DIA) workflow.Proteins that exhibited a significant increase in CAF versus NPF were enriched for the functional categories "cell adhesion" and the "extracellular matrix."The CAF phosphoproteome exhibited enhanced phosphorylation of proteins associated with the "spliceosome" and "actin binding."STRING analysis of the CAF proteome revealed a prominent interaction hub associated with collagen synthesis, modification, and signaling.It contained multiple collagens, including the fibrillar types COL1A1/2 and COL5A1; the receptor tyrosine kinase discoidin domain-containing receptor 2 (DDR2), a receptor for fibrillar collagens; and lysyl oxidase-like 2 (LOXL2), an enzyme that promotes collagen crosslinking.Increased activity and/or expression of LOXL2 and DDR2 in CAF were confirmed by enzymatic assays and Western blotting analyses.Pharmacological inhibition of CAF-derived LOXL2 perturbed extracellular matrix (ECM) organization and decreased CAF migration in a wound healing assay.Further, it significantly impaired the motility of cocultured RWPE-2 prostate tumor epithelial cells.These results indicate that CAF-derived LOXL2 is an important mediator of intercellular communication within the prostate tumor microenvironment and is a potential therapeutic target.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CAFs produce matrix-crosslinking enzymes and, together with force-mediated ECM remodelling, these contribute to increased stiffness of tumour tissue.
“CAFs also produce matrix-crosslinking enzymes and, together with force-mediated ECM remodelling (reviewed in detail85,86), these contribute to the increased stiffness of tumour tissue87–89.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327 · see citing works
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323 · see citing works
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · see citing works
STRING 8--a global view on proteins and their functional interactions in 630 organisms
Jensen, L. J., Kuhn, M., Stark, M., Chaffron, S., Creevey, C. J., Muller, J., Doerks, T., Julien, P., Roth, A. C., Simonovic, M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn760 · Cited by 2,475 · see citing works
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,678 · see citing works
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463 · see citing works
Naba, A., Clauser, K. R., Hoersch, S., Liu, H., Carr, S. A., & Hynes, R. O. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014647 · Cited by 1,354 · see citing works
Bruderer, R., Bernhardt, O. M., Gandhi, T., Miladinović, S. M., Cheng, L.-Y., Messner, S., Ehrenberger, T., Zanotelli, V., Butscheid, Y., Escher, C., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.044305 · Cited by 1,238 · see citing works
Rezakhaniha, R., Agianniotis, A., Schrauwen, J. T. C., Griffa, A., Sage, D., Bouten, C. V. C., van de Vosse, F. N., Unser, M. A., & Stergiopulos, N. (2011) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-011-0325-z · Cited by 1,104 · see citing works
Choi, M., Chang, C.-Y., Clough, T., Broudy, D., Killeen, T., MacLean, B., & Olga Vitek, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu305 · Cited by 1,041 · see citing works
The extracellular matrix: tools and insights for the "omics" era
Naba, A., Clauser, K. R., Ding, H., Whittaker, C. A., Carr, S. A., & Hynes, R. O. (2016) · Matrix Biology · doi:10.1016/j.matbio.2015.06.003 · Cited by 1,037 · see citing works
Balancing forces: architectural control of mechanotransduction
DuFort, C. C., Paszek, M. J., & Weaver, V. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3112 · Cited by 987 · see citing works
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870 · see citing works
Xiong, G., Deng, L., Zhu, J., Rychahou, P. G., & Xu, R. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-1 · Cited by 756 · see citing works
Labernadie, A., Kato, T., Brugués, A., Serra‐Picamal, X., Derzsi, S., Arwert, E. N., Weston, A., González-Tarragó, V., Elósegui-Artola, A., Albertazzi, L., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3478 · Cited by 747 · see citing works
Michalski, A., Cox, J., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr101060v · Cited by 685 · see citing works
Provenzano, P. P., Inman, D. R., Eliceiri, K. W., & Keely, P. J. (2009) · Oncogene · doi:10.1038/onc.2009.299 · Cited by 667 · see citing works
Giannoni, E., Bianchini, F., Masieri, L., Serni, S., Torre, E., Calorini, L., & Chiarugi, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0785 · Cited by 596 · see citing works
The rationale for targeting the LOX family in cancer
Barker, H. E., Cox, T. R., & Erler, J. T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3319 · Cited by 595 · see citing works
Self-citationCollagen as a double-edged sword in tumor progression
Fang, M., Yuan, J., Peng, C., & Li, Y. (2014) · Tumor Biology · doi:10.1007/s13277-013-1511-7 · Cited by 580 · see citing works
Collins, B. C., Hunter, C. L., Liu, Y., Schilling, B., Rosenberger, G., Bader, S. L., Chan, D. W., Gibson, B. W., Gingras, A.-C., Held, J. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00249-5 · Cited by 576 · see citing works
Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin
Erdogan, B., Ao, M., White, L. M., Means, A. L., Brewer, B. M., Yang, L., Washington, M. K., Shi, C., Franco, O. E., Weaver, A. M., et al. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201704053 · Cited by 552 · see citing works
Lysyl oxidases: A novel multifunctional amine oxidase family
Csiszar, K. (2001) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(01)70012-8 · Cited by 514 · see citing works
PAK signalling during the development and progression of cancer
Radu, M., Semenova, G., Kosoff, R. E., & Chernoff, J. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3645 · Cited by 509 · see citing works
REACTIVE STROMA IN PROSTATE CANCER PROGRESSION
Tuxhorn, J. A., Ayala, G. E., & Rowley, D. R. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65620-0 · Cited by 506 · see citing works
Bello, D. (1997) · Carcinogenesis · doi:10.1093/carcin/18.6.1215 · Cited by 433 · see citing works
A repository of assays to quantify 10,000 human proteins by SWATH-MS
Rosenberger, G., Koh, C. C., Guo, T., Röst, H. L., Kouvonen, P., Collins, B. C., Heusel, M., Liu, Y., Caron, E., Vichalkovski, A., et al. (2014) · Scientific Data · doi:10.1038/sdata.2014.31 · Cited by 413 · see citing works
Identification of PLOD2 as Telopeptide Lysyl Hydroxylase, an Important Enzyme in Fibrosis
van der Slot, A. J., Zuurmond, A., Bardoel, A. F. J., Wijmenga, C., Pruijs, H. E. H., Sillence, D. O., Brinckmann, J., Abraham, D., Black, C. M., Verzijl, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307380200 · Cited by 410 · see citing works
Zhang, K., Corsa, C. A. S., Ponik, S. M., Prior, J. L., Piwnica-Worms, D. R., Eliceiri, K. W., Keely, P. J., & Longmore, G. D. (2013) · Nature Cell Biology · doi:10.1038/ncb2743 · Cited by 393 · see citing works
p21-Activated Kinase 1 (Pak1) Regulates Cell Motility in Mammalian Fibroblasts
Sells, M. A., Boyd, J. T., & Chernoff, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.4.837 · Cited by 385 · see citing works
Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
Naba, A., Clauser, K. R., Lamar, J. M., Carr, S. A., & Hynes, R. O. (2014) · eLife · doi:10.7554/elife.01308 · Cited by 377 · see citing works
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
Ayala, G., Tuxhorn, J. A., Wheeler, T. M., Frolov, A., Scardino, P. T., Ohori, M., Wheeler, M., Spitler, J., & Rowley, D. R. (2003) · PubMed · Cited by 355 · see citing works
Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation
Zhang, D., Wang, Y., Shi, Z., Liu, J., Sun, P., Hou, X., Zhang, J., Zhao, S., Zhou, B. P., & Mi, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.006 · Cited by 334 · see citing works
Baker, A.-M., Bird, D., Lang, G., Cox, T. R., & Erler, J. T. (2012) · Oncogene · doi:10.1038/onc.2012.202 · Cited by 332 · see citing works
Self-citationThe reactive stroma microenvironment and prostate cancer progression
Barron, D. A., & Rowley, D. R. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0085 · Cited by 331 · see citing works
Scheltema, R. A., Hauschild, J.-P., Lange, O., Hornburg, D., Denisov, E. V., Damoc, E., Kuehn, A., Makarov, A., & Mann, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.043489 · Cited by 321 · see citing works
Preparation of extracellular matrices produced by cultured and primary fibroblasts
Franco-Barraza, J., Beacham, D. A., Amatangelo, M., & Cukierman, E. (2006) · Current Protocols in Cell Biology · doi:10.1002/cpcb.2 · Cited by 297 · see citing works
Ao, M., Franco, O. E., Park, D., Raman, D., Williams, K., & Hayward, S. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3946 · Cited by 276 · see citing works
Schiller, H. B., Fernandez, I. E., Burgstaller, G., Schaab, C., Scheltema, R. A., Schwarzmayr, T., Strom, T. M., Eickelberg, O., & Mann, M. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156123 · Cited by 261 · see citing works
Aurbach-Klipper, Y., Wasserman, M., Braunspiegel-Weintrob, N., Borstein, D., Peleg, S., ASSA, S., Karp, M., Benjamini, Y., Hochberg, Y., & Laron, Z. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90228-7 · Cited by 258 · see citing works
LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
Barker, H. E., Chang, J., Cox, T. R., Lang, G., Bird, D., Nicolau, M. M., Evans, H., Gartland, A., & Erler, J. T. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2868 · Cited by 253 · see citing works
Self-citationAstin, J. W., Batson, J., Kadir, S. R., Charlet, J., Persad, R. A., Gillatt, D. A., Oxley, J., & Nobes, C. D. (2010) · Nature Cell Biology · doi:10.1038/ncb2122 · Cited by 245 · see citing works
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
Santi, A., Kugeratski, F. G., & Zanivan, S. R. (2017) · PROTEOMICS · doi:10.1002/pmic.201700167 · Cited by 239 · see citing works
A Fluorometric Assay for Detection of Lysyl Oxidase Enzyme Activity in Biological Samples
Palamakumbura, A. H., & Trackman, P. C. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5464 · Cited by 228 · see citing works
Peng, L., Ran, Y., Hu, H., Yu, L., Liu, Q., Zhou, Z., Sun, Y.-M., Sun, L.-C., Pan, J., Sun, L., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp178 · Cited by 204 · see citing works
Rosenberger, G., Bludau, I., Schmitt, U., Heusel, M., Hunter, C. L., Liu, Y., MacCoss, M. J., MacLean, B. X., Nesvizhskii, A. I., Pedrioli, P. G. A., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4398 · Cited by 203 · see citing works
Memarzadeh, S., Xin, L., Mulholland, D. J., Mansukhani, A., Wu, H., Teitell, M. A., & Witte, O. N. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.002 · Cited by 201 · see citing works
Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
Hanley, C. J., Mellone, M., Ford, K., Thirdborough, S. M., Mellows, T., Frampton, S. J., Smith, D. M., Harden, E., Szyndralewiez, C., Bullock, M., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx121 · Cited by 195 · see citing works
Tumor stroma as targets for cancer therapy
Zhang, J., & Liu, J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.003 · Cited by 185 · see citing works
Vadasz, Z., Kessler, O., Akiri, G., Gengrinovitch, S., Kagan, H. M., Baruch, Y., Izhak, O. B., & Neufeld, G. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.052 · Cited by 182 · see citing works
Mayorca‐Guiliani, A. E., Madsen, C. D., Cox, T. R., Horton, E. R., Venning, F. A., & Erler, J. T. (2017) · Nature Medicine · doi:10.1038/nm.4352 · Cited by 177 · see citing works
Self-citationGlobal Gene Expression Analysis of Reactive Stroma in Prostate Cancer
Dakhova, O., Özen, M., Creighton, C. J., Li, R., Ayala, G., Rowley, D. R., & Ittmann, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1899 · Cited by 166 · see citing works
Sung, S., Hsieh, C., Law, A., Zhau, H. E., Pathak, S., Multani, A. S., Lim, S., Coleman, I. M., Wu, L.-C., Figg, W. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2492 · Cited by 161 · see citing works
Joesting, M. S., Perrin, S., Elenbaas, B., Fawell, S. E., Rubin, J. S., Franco, O. E., Hayward, S. W., Cunha, G. R., & Marker, P. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0824 · Cited by 159 · see citing works
Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis
Wong, G. S., & Rustgi, A. K. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.592 · Cited by 158 · see citing works
Moreno‐Bueno, G., Salvador, F., Martín, A., Floristán, A., Cuevas, E. P., Santos, V., Montes, A., Morales, S., Castilla, M. Á., Rojo‐Sebastián, A., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100156 · Cited by 157 · see citing works
Cunha, G. R. (1972) · The Anatomical Record · doi:10.1002/ar.1091720206 · Cited by 155 · see citing works
Calvo, F., Ranftl, R., Hooper, S., Farrugia, A. J., Moeendarbary, E., Bruckbauer, A., Batista, F., Charras, G., & Sahai, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.052 · Cited by 142 · see citing works
Mesker, W. E., Liefers, G., Junggeburt, J. M. C., van Pelt, G. W., Alberici, P., Kuppen, P. J. K., de Miranda, N. F. C. C., van Leeuwen, K. A. M., Morreau, H. M., Szuhai, K., et al. (2009) · Analytical Cellular Pathology · doi:10.1155/2009/214085 · Cited by 140 · see citing works
Yanagisawa, N., Li, R., Rowley, D. R., Liu, H., Kadmon, D., Miles, B. J., Wheeler, T. M., & Ayala, G. E. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.04.008 · Cited by 140 · see citing works
Naba, A., Clauser, K. R., & Hynes, R. O. (2015) · Journal of Visualized Experiments · doi:10.3791/53057 · Cited by 135 · see citing works
Grossman, M., Ben‐Chetrit, N., Zhuravlev, A., Afik, R., Bassat, E., Solomonov, I., Yarden, Y., & Sagi, I. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2813 · Cited by 134 · see citing works
Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth
González, M. E., Martin, E. E., Anwar, T., Arellano-Garcia, C., Medhora, N., Lama, A., Chen, Y., Tanager, K. S., Yoon, E., Kidwell, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.079 · Cited by 133 · see citing works
The prognostic value of tumour-stroma ratio in triple-negative breast cancer
Moorman, A. M., Vink, R., Heijmans, H. J., van der Palen, J. A. M., & Kouwenhoven, E. A. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.01.002 · Cited by 132 · see citing works
Deramaudt, T. B., Dujardin, D., Hamadi, A., Noulet, F., Kolli, K. P., Mey, J. D., Takeda, K., & Rondé, P. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0725 · Cited by 127 · see citing works
Goicoechea, S. M., García-Mata, R., Staub, J., Valdivia, A., Sharek, L., McCulloch, C. G., Hwang, R. F., Urrutia, R., Yeh, J. J., Kim, H. J., et al. (2014) · Oncogene · doi:10.1038/onc.2013.68 · Cited by 121 · see citing works
True, L. D., Zhang, H., Ye, M., Huang, C.-Y., Nelson, P. S., von Haller, P. D., Tjoelker, L. W., Kim, J., Qian, W., Smith, R. D., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.122 · Cited by 121 · see citing works
Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling
Barker, H. E., Bird, D., Lang, G., & Erler, J. T. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0033-t · Cited by 119 · see citing works
Barclay, W. W., Woodruff, R. D., Hall, M. C., & Cramer, S. D. (2004) · Endocrinology · doi:10.1210/en.2004-1123 · Cited by 118 · see citing works
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
Chang, J., Lucas, M. C., Leonte, L. E., García-Montolio, M., Singh, L. B., Findlay, A. D., Deodhar, M., Foot, J. S., Jarolimek, W., Timpson, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15257 · Cited by 113 · see citing works
Self-citationA preclinical xenograft model of prostate cancer using human tumors
Lawrence, M. G., Taylor, R. A., Toivanen, R., Pedersen, J., Norden, S., Pook, D. W., Frydenberg, M., BioResource, A. P. C., Papargiris, M., Niranjan, B., et al. (2013) · Nature Protocols · doi:10.1038/nprot.2013.043 · Cited by 111 · see citing works
Self-citationCancer-Associated Fibroblasts Enhance the Gland-Forming Capability of Prostate Cancer Stem Cells
Liao, C., Adisetiyo, H., Liang, M., & Roy‐Burman, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3982 · Cited by 110 · see citing works
Corsa, C. A. S., Brenot, A., Grither, W. R., Hove, S. V., Loza, A. J., Zhang, K., Ponik, S. M., Liu, Y., DeNardo, D. G., Eliceiri, K. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.033 · Cited by 108 · see citing works
The function and mechanisms of action of LOXL2 in cancer (Review)
Wu, L., & Zhu, Y. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2337 · Cited by 101 · see citing works
Diagnosis of Prostate Cancer Using Differentially Expressed Genes in Stroma
Jia, Z., Wang, Y., Sawyers, A., Yao, H., Rahmatpanah, F. B., Xia, X.-Q., Xu, Q., Pio, R., Turan, T., Koziol, J. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2585 · Cited by 99 · see citing works
Enduring epigenetic landmarks define the cancer microenvironmentPreprint
Pidsley, R., Lawrence, M. G., Zotenko, E., Niranjan, B., Statham, A. L., Song, J. Z., Chabanon, R. M., Qu, W., Wang, H., Richards, M. G., et al. (2018) · Genome Research · doi:10.1101/gr.229070.117 · Cited by 98 · see citing works
Self-citationCancer-Associated Fibroblasts: Perspectives in Cancer Therapy
Prakash, J. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.04.005 · Cited by 84 · see citing works
Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer
Kasashima, H., Yashiro, M., Kinoshita, H., Fukuoka, T., Morisaki, T., Masuda, G., Sakurai, K., Kubo, N., Ohira, M., & Hirakawa, K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.014 · Cited by 82 · see citing works
Structure and Function of a Prostate Cancer Dissemination–Permissive Extracellular Matrix
Penet, M., Kakkad, S. M., Pathak, A. P., Krishnamachary, B., Mironchik, Y., Raman, V., Solaiyappan, M., & Bhujwalla, Z. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1516 · Cited by 75 · see citing works
Paland, N., Kamer, I., Kogan-Sakin, I., Madar, S., Goldfinger, N., & Rotter, V. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0073 · Cited by 70 · see citing works
In vitro modeling of the prostate cancer microenvironment
Ellem, S. J., De-Juan-Pardo, E. M., & Risbridger, G. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.008 · Cited by 68 · see citing works
Self-citationTargeting microenvironment in cancer therapeutics
Martin, M., Han, W., & Lu, T. (2016) · Oncotarget · doi:10.18632/oncotarget.9824 · Cited by 66 · see citing works
Effect of FAK inhibitor VS‐6063 (defactinib) on docetaxel efficacy in prostate cancer
Lin, H., Lee, B. Y., Castillo, L. E., Spielman, C., Grogan, J., Yeung, N. K., Kench, J. G., Stricker, P. D., Haynes, A., Centenera, M. M., et al. (2018) · The Prostate · doi:10.1002/pros.23476 · Cited by 64 · see citing works
Self-citationClark, A. K., Taubenberger, A. V., Taylor, R. A., Niranjan, B., Chea, Z. Y., Zotenko, E., Sieh, S., Pedersen, J. S., Norden, S., Frydenberg, M., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.005 · Cited by 63 · see citing works
Self-citationThe Stroma—A Key Regulator in Prostate Function and Malignancy
Hägglöf, C., & Bergh, A. R. J. (2012) · Cancers · doi:10.3390/cancers4020531 · Cited by 62 · see citing works
Mota‐Peynado, A. D. L., Chernoff, J., & Beeser, A. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.181743 · Cited by 61 · see citing works
Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration
Schilter, H. C., Collison, A., Russo, R. C., Foot, J. S., Yow, T. T., Vieira, A. T., Tavares, L. D., Mattes, J. E., Teixeira, M. M., & Jarolimek, W. (2015) · Respiratory Research · doi:10.1186/s12931-015-0200-z · Cited by 58 · see citing works
Pereira, B., Lister, N. L., Hashimoto, K., Teng, L., Flandes‐Iparraguirre, M., Eder, A., Sánchez‐Herrero, A., Niranjan, B., Frydenberg, M., Papargiris, M., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.030 · Cited by 55 · see citing works
Self-citationDistinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues
Zhao, H., Ramos, C. F., Brooks, J. D., & Peehl, D. M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20828 · Cited by 55 · see citing works
Majkowska, I., Shitomi, Y., Ito, N., Gray, N. S., & Itoh, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.770057 · Cited by 50 · see citing works
Ling, Y., Li, C., Feng, K., Palmer, S. G., Appleton, P. L., Lang, S., McGloin, D., Huang, Z., & Nabi, G. (2016) · Journal of Biophotonics · doi:10.1002/jbio.201600090 · Cited by 49 · see citing works
Wilkinson, S. E., Furic, L., Buchanan, G., Larsson, O. S., Pedersen, J., Frydenberg, M., Risbridger, G. P., & Taylor, R. A. (2013) · The Prostate · doi:10.1002/pros.22720 · Cited by 46 · see citing works
Self-citationThe influence of discoidin domain receptor 2 on the persistence length of collagen type I fibers
Sivakumar, L., & Agarwal, G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.070 · Cited by 45 · see citing works
Does the microenvironment influence the cell types of origin for prostate cancer?Preprint
Goldstein, A. S., & Witte, O. N. (2013) · Genes & Development · doi:10.1101/gad.222380.113 · Cited by 33 · see citing works
Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer
Kato, M., Kurozumi, A., Goto, Y., Matsushita, R., Okato, A., Nishikawa, R., Fukumoto, I., Koshizuka, K., Ichikawa, T., & Seki, N. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.68 · Cited by 32 · see citing works
Henke, A., Franco, O. E., Stewart, G. D., Riddick, A. C. P., Katz, E., Hayward, S. W., & Thomson, A. A. (2016) · Cancers · doi:10.3390/cancers8090077 · Cited by 18 · see citing works
Flagged first, then by citations
2 of the 98 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [65]Bruderer R., Bernhardt O. M., Gandhi T., Miladinovic S. M., Cheng L. Y., Messner S., Ehrenberger T., Zanotelli V., Butscheid Y., Escher C., Vitek O., Rinner O., and Reiter L. (2015) Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol. Cell. Proteomics 14, 1400– 1410 25724911 PMC4424408
- [92]Radu M., Semenova G., Kosoff R., and Chernoff J. (2014) Pak Signaling in the Development and Progression of Cancer. Nature Rev. Cancer 14, 13– 25 24505617 PMC4115244
Cited by
Sorted by citations
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · see citing works
Cox, T. R. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 978 · see citing works
Self-citationYuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977 · see citing works
The cancer-immunity cycle: Indication, genotype, and immunotype
Mellman, I., Chen, D. S., Powles, T. B., & Turley, S. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.011 · Cited by 985 · see citing works
Cancer-associated fibroblasts: from basic science to anticancer therapy
Yang, D., Liu, J., Qian, H., & Zhuang, Q. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01013-0 · Cited by 572 · see citing works
Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer
Wu, S. Z., Roden, D. L., Wang, C., Holliday, H., Harvey, K., Cazet, A., Murphy, K. J., Pereira, B., Al‐Eryani, G., Bartoniček, N., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104063 · Cited by 436 · see citing works
Self-citationZhang, H., Yue, X., Chen, Z., Liu, C., Wu, W., Zhang, N., Liu, Z., Yang, L., Jiang, Q., Cheng, Q., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01860-5 · Cited by 435 · see citing works
The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis
Dzobo, K., & Dandara, C. (2023) · Biomimetics · doi:10.3390/biomimetics8020146 · Cited by 209 · see citing works
The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
Bonollo, F., Thalmann, G. N., Julio, M. K., & Karkampouna, S. (2020) · Cancers · doi:10.3390/cancers12071887 · Cited by 169 · see citing works
Kasashima, H., Durán, Á., Martínez-Ordóñez, A., Nakanishi, Y., Kinoshita, H., Linares, J. F., Reina‐Campos, M., Kudo, Y., L’Hermitte, A., Yashiro, M., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.10.014 · Cited by 116 · see citing works
Navigating the Collagen Jungle: The Biomedical Potential of Fiber Organization in Cancer
Ouellette, J. N., Drifka, C. R., Pointer, K. B., Liu, Y., Lieberthal, T. J., Kao, W. J., Kuo, J. S., Loeffler, A. G., & Eliceiri, K. W. (2021) · Bioengineering · doi:10.3390/bioengineering8020017 · Cited by 78 · see citing works
Cancer: a mirrored room between tumor bulk and tumor microenvironment
Hernández-Camarero, P., López‐Ruiz, E., Marchal, J. A., & Perán, M. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02022-5 · Cited by 80 · see citing works
Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment
Raaijmakers, K., Adema, G. J., Bussink, J., & Ansems, M. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03251-0 · Cited by 71 · see citing works
Revisiting the role of cancer-associated fibroblasts in tumor microenvironment
Lan, X., Li, W., Zhao, K., Wang, J., Li, S., & Hai, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582532 · Cited by 72 · see citing works
Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes
Baker, A. T., Abuwarwar, M. H., Poly, L., Wilkins, S., & Fletcher, A. L. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001203 · Cited by 68 · see citing works
Yamauchi, M., Gibbons, D. L., Zong, C. C., Fradette, J. J., Bota‐Rabassedas, N., & Kurie, J. M. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.05.001 · Cited by 66 · see citing works
Yu, S., Wang, S., Wang, X., & Xu, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03518-8 · Cited by 65 · see citing works
Bedeschi, M., Marino, N., Cavassi, E., Piccinini, F., & Tesei, A. (2023) · Cells · doi:10.3390/cells12050802 · Cited by 55 · see citing works
Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy
De, P. K., Aske, J. C., & Dey, N. (2021) · Cancers · doi:10.3390/cancers13205246 · Cited by 52 · see citing works
Zhang, Y., Yin, C., Wei, C., Xia, S., Zhu, Q., Zhang, X., Yu, B., Zhou, J. Y., & Wang, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106534 · Cited by 50 · see citing works
“Stromal cells in prostate cancer pathobiology: friends or foes?”
Pederzoli, F., Raffo, M., Pakula, H., Ravera, F., Nuzzo, P. V., & Loda, M. F. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02085-x · Cited by 49 · see citing works
The Interplay between T Cells and Cancer: The Basis of Immunotherapy
Chen, C., Liu, X., Chang, C., Wang, H. Y., & Wang, R. (2023) · Genes · doi:10.3390/genes14051008 · Cited by 39 · see citing works
Post-Translational Modifications That Drive Prostate Cancer Progression
Samaržija, I. (2021) · Biomolecules · doi:10.3390/biom11020247 · Cited by 39 · see citing works
Zhang, W., Wang, J., Liu, C., Li, Y., Sun, C., Wu, J., & Wu, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04714-2 · Cited by 40 · see citing works
Self-citationHuang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 46 · see citing works
Chen, H., Fang, S.-P., Zhu, X., & Liu, H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1412337 · Cited by 32 · see citing works
Li, L., Liu, Z., Quan, J., Sun, J., Lu, J., & Zhao, G. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113736 · Cited by 32 · see citing works
Lawrence, M. G., Pidsley, R., Niranjan, B., Papargiris, M., Pereira, B., Richards, M. G., Teng, L., Norden, S., Ryan, A., Frydenberg, M., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00836-2 · Cited by 31 · see citing works
Self-citationRivello, F., Matuła, K., Piruska, A., Smits, M., Mehra, N., & Huck, W. T. S. (2020) · Science Advances · doi:10.1126/sciadv.aaz3849 · Cited by 30 · see citing works
Davies, R. G., Liu, L., Sheng, T., Tuano, N., Chaturvedi, R., Huang, K. K., Itman, C., Mandoli, A., Qamra, A., Hu, C., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02266-6 · Cited by 30 · see citing works
Self-citationCoelho, N. M., Wang, A. A., & McCulloch, C. A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.07.005 · Cited by 28 · see citing works
Pruitt, H. C., Guan, Y., Liu, H., Carey, A. E., Brennen, W. N., Lu, J., Joshu, C. E., Weeraratna, A. T., Lotan, T. L., Eisinger‐Mathason, T. S. K., et al. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.06.002 · Cited by 29 · see citing works
Chen, L., Wang, Y.-Y., Deng, L., Wang, C., Wang, S.-Y., Shao, S., Zhu, Z., Zhao, J., Zhang, Y., Ruan, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.017 · Cited by 28 · see citing works
Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate cancer
Zhou, H., He, Q., Li, C., Alsharafi, B. L. M., Deng, L. H., Long, Z., & Gan, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.955669 · Cited by 28 · see citing works
Lin, S., Zheng, L., Lu, Y., Xia, Q., Zhou, P., & Liu, Z. (2020) · Cancer Medicine · doi:10.1002/cam4.3472 · Cited by 27 · see citing works
An overview of advances in multi-omics analysis in prostate cancer
Zhang, E., Zhang, M., Shi, C., Sun, L., Shan, L., Zhang, H., & Song, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118376 · Cited by 26 · see citing works
Hachem, S., Yehya, A., Masri, J. E., Mavingire, N., Johnson, J. R., Dwead, A. M., Kattour, N., Bouchi, Y., Kobeissy, F. H., Rais‐Bahrami, S., et al. (2024) · Biology · doi:10.3390/biology13100762 · Cited by 27 · see citing works
Musa, M., & Ali, A. (2020) · Future Oncology · doi:10.2217/fon-2020-0384 · Cited by 25 · see citing works
Li, P., Cao, J., Li, J., Yao, Z., Han, D., Ying, L., Wang, Z., & Tian, J. (2020) · Cancer Medicine · doi:10.1002/cam4.3372 · Cited by 25 · see citing works
Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment
Teng, L., Pereira, B., Keerthikumar, S., Huang, C., Niranjan, B., Lee, S. N., Richards, M. G., Schittenhelm, R. B., Furic, L., Goode, D. L., et al. (2021) · Cancers · doi:10.3390/cancers13061237 · Cited by 25 · see citing works
Self-citationThe multifaceted role of the stroma in the healthy prostate and prostate cancer
Carlo, E. D., & Sorrentino, C. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05564-2 · Cited by 25 · see citing works
Zhang, Z., Tang, Y., Luo, D., Qiu, J. L., & Chen, L. (2025) · APL Bioengineering · doi:10.1063/5.0244706 · Cited by 23 · see citing works
Jaeschke, A., Jacobi, A., Lawrence, M., Risbridger, G., Frydenberg, M., Williams, E., Vela, I., Hutmacher, D., Bray, L., & Taubenberger, A. (2020) · Materials Today Bio · doi:10.1016/j.mtbio.2020.100073 · Cited by 16 · see citing works
Self-citationModi, U., Makwana, P., & Vasita, R. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103511 · Cited by 23 · see citing works
New Insights and Emerging Therapeutic Approaches in Prostate Cancer
Licitra, F., Giovannelli, P., Donato, M. D., Monaco, A., Galasso, G., Migliaccio, A., & Castoria, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.840787 · Cited by 19 · see citing works
Zhai, X., Chen, X., Wan, Z., Ge, M., Ding, Y., Gu, J., Hua, J., Guo, D., Tan, M., & Xu, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1136835 · Cited by 19 · see citing works
Choi, K., Kim, B., Lee, S., Han, J., Bae, H.-S., Han, S.-B., Lee, D., Ham, I., Hur, H., Kim, E., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01396-7 · Cited by 19 · see citing works
Ma, C.-Y., Wang, S., Wang, G., Wu, Y., Yang, T., Shen, W., Zhuang, Y., Zhang, L., Liu, X., Yang, L., et al. (2020) · Journal of Clinical Apheresis · doi:10.1002/jca.21781 · Cited by 18 · see citing works
Self-citationFibroblasts: The grey eminence of mammary gland development
Sumbal, J., Belisova, D., & Koledova, Z. S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.10.012 · Cited by 18 · see citing works
Liu, L., Zhang, Y., Liu, H., Yang, J., Tian, Q., Chueakula, N., Ramasamy, S. K., Verma, N. K., Cheung, C., & Kusumbe, A. P. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4744 · Cited by 16 · see citing works
Sadeesh, N., Scaravilli, M., & Latonen, L. (2021) · Cancers · doi:10.3390/cancers13194829 · Cited by 16 · see citing works
Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice
Punetha, A., & Kotiya, D. (2023) · Proteomes · doi:10.3390/proteomes11010002 · Cited by 12 · see citing works
Booijink, R. S., Terstappen, L. W. M. M., Dathathri, E., Isebia, K. T., Kraan, J., Martens, J. W. M., & Bansal, R. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13653 · Cited by 15 · see citing works
McGovern, J., Bock, N., Shafiee, A., Martine, L. C., Wagner, F., Baldwin, J., Landgraf, M., Lahr, C. A., Meinert, C., Williams, E. D., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02527-x · Cited by 15 · see citing works
Self-citationYang, X., Cruz, M. I., Nguyen, E. V., Huang, C., Schittenhelm, R. B., Luu, J., Cowley, K. J., Shin, S., Nguyen, L. K., Sian, T. C. C. L. K., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02594-w · Cited by 15 · see citing works
Self-citationImplementation of Mass Spectrometry Imaging in Pathology
Gonçalves, J. P. L., Bollwein, C., Weichert, W., & Schwamborn, K. (2021) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2021.03.001 · Cited by 14 · see citing works
Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases
Perryman, L., & Gray, S. G. (2022) · Cancers · doi:10.3390/cancers14040981 · Cited by 13 · see citing works
Fan, Z., Liu, Y., Liu, X., Nian, W., Huang, X., Yang, Q., Hou, S., & Chen, F. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03133-5 · Cited by 13 · see citing works
Hou, J., Nguyen, E. V., Surudoi, M., Roy, M. J., Patel, O., Lucet, I. S., Ma, X., & Daly, R. J. (2022) · Science Signaling · doi:10.1126/scisignal.abj3554 · Cited by 12 · see citing works
Self-citationCai, M., Zheng, F., Ren, Y.-Z., Zhen, C., Fu, D., Song, X., Li, Q., Qu, Y., Chen, Z., & Zhao, S. (2025) · Research · doi:10.34133/research.0791 · Cited by 12 · see citing works
Lv, Y., Hu, J., Zheng, W., Shan, L., Bai, B., Zhu, H., & Dai, S. (2023) · Translational Cancer Research · doi:10.21037/tcr-23-261 · Cited by 10 · see citing works
Wittka, A., Ketteler, J., Borgards, L., Maier, P., Herskind, C., Jendrossek, V., & Klein, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.802482 · Cited by 9 · see citing works
Kader, A., Snellings, J., Adams, L. C., Gottheil, P., Mangarova, D. B., Heyl, J. L., Kaufmann, J. O., Möckel, J., Brangsch, J., Auer, T. A., et al. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.213884 · Cited by 8 · see citing works
Lupsa, N., Héninger, E., Ding, A. B., Sánchez‐de‐Diego, C., Vietor, K. J., Reese, S. R., LeBeau, A. M., Kosoff, D., Beebe, D. J., Kerr, S. C., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031585 · Cited by 8 · see citing works
The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary system
Hong, R., Yu, P., Zhang, X., Su, P. C., Liang, H., Dong, D. F., Wang, X., & Wang, K. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70299 · Cited by 8 · see citing works
Blockage of Squamous Cancer Cell Collective Invasion by FAK Inhibition Is Released by CAFs and MMP-2
Sáenz‐de‐Santa‐María, I., Celada, L., Martínez, A. S. J., Cubiella, T., & Chiara, M. (2020) · Cancers · doi:10.3390/cancers12123708 · Cited by 8 · see citing works
Sorrentino, C., D’Angiolo, R., Gentile, G., Giovannelli, P., Perillo, B., Migliaccio, A., Castoria, G., & Donato, M. D. (2023) · Endocrines · doi:10.3390/endocrines4020027 · Cited by 7 · see citing works
Research progress and application of single-cell sequencing in head and neck malignant tumors
Qu, S., Gong, M., Deng, Y., Xiang, Y., & Ye, D. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00691-2 · Cited by 7 · see citing works
Wu, Y., Clark, K. C., Nguyen, E. V., Niranjan, B., Horvath, L. G., Taylor, R. A., & Daly, R. J. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00719-z · Cited by 7 · see citing works
Self-citationKazakova, A. N., Anufrieva, K. S., Ivanova, O. M., Shnaider, P. V., Malyants, I. K., Aleshikova, O. I., Slonov, A. V., Ashrafyan, L. A., Babaeva, N. A., Валерьевич, Е. А., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.825014 · Cited by 7 · see citing works
-Omics approaches to study and model cell-cell interactions in engineered tissues
Stark, C., Jenison, S. E., & Ngo, M. T. (2025) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2025.1629455 · Cited by 7 · see citing works
Xu, W., Goreczny, G. J., Forsythe, I., Brennan, G., Stowell, T., Brock, K., Capella, B., & Turner, C. E. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.113930 · Cited by 7 · see citing works
Wei, J., Lu, Y., Lu, J., Wang, Z., Yan, Y., Liang, B., Qian, S., Ni, J., Yang, Y., Huang, S., et al. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1476092 · Cited by 6 · see citing works
Contributions of carcinoma-associated fibroblasts to the prostate cancer microenvironment
Vickman, R. E., Franco, O. E., & Hayward, S. W. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.01.004 · Cited by 6 · see citing works
The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells
Samaržija, I., Lukiyanchuk, V., Lončarić, M., Rac, A., Stojanović, N., Gorodetska, I., Kahya, U., Humphries, J. D., Fatima, M., Humphries, M. J., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1452463 · Cited by 5 · see citing works
Clark, K. C., Nguyen, E. V., Niranjan, B., Wu, Y., Sian, T. C. C. L. K., Horvath, L. G., Taylor, R. A., & Daly, R. J. (2023) · Cancers · doi:10.3390/cancers15030699 · Cited by 5 · see citing works
Self-citationMechanical cues shaping cancer cell-microbiota interaction dynamics in tumor progression
Zhou, Y., Zhou, X., Zhu, X., Feng, X., & Li, F. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102612 · Cited by 4 · see citing works
Qian, F., Zhou, J., Tang, Y., Chen, J., Zuo, J., Gou, K., Tan, C., Fang, J., Zhao, Z., Zhao, J., et al. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s588669 · Cited by 4 · see citing works
Dewdney, B., Miranda, P. J., Kuchibhotla, M., Palanisamy, R., Richworth, C. M., Milligan, C. J., Ng, Z. Y., Ursich, L. T., Petrou, S., Fletcher, E. V., et al. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae187 · Cited by 4 · see citing works
Self-citationWang, J., Chen, M., Wei, G., Zou, F., Gu, J., Cao, Y., Deng, S., & Cai, K. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155994 · Cited by 4 · see citing works
Research progress on the role of biomechanical clues in the progression of lung cancer
Gong, F., Zhang, Q., Qin, F., Qu, R., Wang, C., Yang, T., Fan, T., Lv, Y., & Dai, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1581831 · Cited by 3 · see citing works
Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review)
Benešová, I., Kalkusova, K., Kwon, Y., Táborská, P., Stakheev, D., Krausová, K., Smetanová, J., Ozaniak, A., Bartůňková, J., Smrž, D., et al. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5785 · Cited by 2 · see citing works
Research progress on tumor extracellular matrix stiffness and immunosuppression
Wu, F., Zhang, P., Wu, W., Tian, H., Jiang, X., & Huang, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1852616 · Cited by 2 · see citing works
PEAK3 pseudokinase represents a pro-migratory and -invasive signalling scaffoldPreprint
Hou, J., Nguyen, E. V., Surudoi, M., Roy, M. J., Patel, O., Lucet, I. S., Ma, X., & Daly, R. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.17.431740 · Cited by 2 · see citing works
Self-citationLai, Z., Hu, C., Jie, J., Xiao, Y., Zhu, Y., Guo, X., Liu, Y., Wang, Y., Pang, S., Zeng, X., et al. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.06.008 · Cited by 1 · see citing works
Khan, A. A., Nema, P., Kashaw, V., & Kashaw, S. K. (2025) · Talanta · doi:10.1016/j.talanta.2025.129132 · Cited by 1 · see citing works
Garside, A., Jacobi, A., Keerthikumar, S., Mahajan, V., Richards, M. G., Niranjan, B., Teng, L., Choo, N., Wei, J. L. J., Risbridger, G. P., et al. (2026) · Advanced Science · doi:10.1002/advs.202522440 · Cited by 1 · see citing works
Self-citationChallenges of Targeting Tumor Microenvironment in Prostate Cancer
Li, G., & Chen, Z. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005744 · Cited by 1 · see citing works
Abikar, A., Mohammad, M. M. S., Athalye, R. R., Nadig, N., Tamboli, N., Babu, V., Keshavamurthy, R., & Ranganathan, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.09.627457 · Cited by 1 · see citing works
Garside, A., Jacobi, A., Keerthikumar, S., Mahajan, V., Richards, M. G., Niranjan, B., Teng, L., Choo, N., Risbridger, G. P., Lawrence, M. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.21.644569 · Cited by 1 · see citing works
Self-citationc-Jun and its targets in fibrosarcoma and melanoma cells
Kielosto, M. (2020) · Työväentutkimus Vuosikirja
Applications of Prostate Cancer Proteomics: A Review
Moita, B., & Sharma, V. (2021) · doi:10.22186/jyi.39.4.45-53
Timpson, P. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737260944.793580089
Davies, R. G., Liu, L., Sheng, T., Tuano, N., Chaturvedi, R., Huang, K. K., Itman, C., Mandoli, A., Qamra, A., Hu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13647263
Self-citationThe Role of Lysine Tyrosylquinone Containing Oxidases in Progression of Solid Tumors
Korneenko, T. V., Pestov, N. B., & Barlev, N. A. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl36248
Davies, R. G., Liu, L., Sheng, T., Tuano, N., Chaturvedi, R., Huang, K. K., Itman, C., Mandoli, A., Qamra, A., Hu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13647266
Self-citationChoi, K.-M., Kim, B., Lee, S.-M., Han, J., Bae, H.-S., Han, S.-B., Lee, D., 함인혜, Hur, H., Kim, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24934683
Choi, K.-M., Kim, B., Lee, S.-M., Han, J., Bae, H.-S., Han, S.-B., Lee, D., 함인혜, Hur, H., Kim, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24934045
Lawrence, M. G., Pidsley, R., Niranjan, B., Papargiris, M., Pereira, B. A., Richards, M. G., Teng, L., Norden, S., Ryan, A., Frydenberg, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12004671
Self-citationDavies, R. G., Liu, L., Sheng, T., Tuano, N., Chaturvedi, R., Huang, K. K., Itman, C., Mandoli, A., Qamra, A., Hu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13647260
Self-citation
- Authors
- Nguyen, E. V., Pereira, B. A., Lawrence, M. G., Ma, X., Rebello, R. J., Chan, H., Niranjan, B., Wu, Y., Ellem, S., Guan, X., Wu, J., Skhinas, J. N., Cox, T. R., Risbridger, G. P., Taylor, R. A., Lister, N. L., & Daly, R. J.
- Affiliations
- Peter MacCallum Cancer Centre (AU)
- University of Southern Queensland (AU)
- Peking University Cancer Hospital (CN)
- Garvan Institute of Medical Research (AU)
- The University of Melbourne (AU)
- Corresponding author
- Daly, Roger J.
- ORCID
- Venue
- Molecular & Cellular Proteomics
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 18
- Issue
- 7
- Pages
- 1410-1427
- ISSN
- 1535-9476 (ISSN-L)
- PMC
- PMC6601211
- OpenAlex
- W2944168058
- Cited by
- 107
- References
- 98
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 15 · 2023: 17 · 2022: 10 · 2021: 17 · 2020: 19 · 2019: 1
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular & Cellular Proteomics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Southern Queensland ePrints (University of Southern Queensland) (acceptedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Cancer Australia (ID NCG2616)
- Faculty of Medicine, Nursing and Health Sciences, Monash University (SGS16–0295)
- Department of Health | National Health and Medical Research Council (NHMRC) (1102752, 1058540)
- Victorian Cancer Agency (VCA) (15023)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- prostate cancer, cancer-associated fibroblasts, LOXL2, DDR2, tumor microenvironment, extracellular matrix, collagen cross-linking, phosphoproteome, proteomic profiling, intercellular communication, therapeutic target
- MeSH terms
- Cancer-Associated Fibroblasts, Amino Acid Oxidoreductases, Cell Movement, Epithelial Cells, Extracellular Matrix, Humans, Male, Neoplasm Proteins, Phosphoproteins, Phosphorylation, Prostate, Prostatic Neoplasms, Reproducibility of Results, Signal Transduction, Autocrine Communication, Paracrine Communication, Proteome, Proteomics, Cell Line, Tumor, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review